LUMINATE AESTHETICS LTD

Executive Summary

Luminate Aesthetics Ltd is a micro-sized, privately controlled aesthetics business that has shown improved liquidity and solvency in its most recent financial year. While the company is compliant with statutory filings and demonstrates better short-term financial health, its small scale, concentrated control, and limited operational data suggest moderate risk. Careful review of revenue sustainability and governance practices is recommended before investment consideration.

LUMINATE AESTHETICS LTD - Analysis Report

Company Number: 14265881

Analysis Date: 2025-07-29 12:09 UTC

1. Risk Rating: LOW to MEDIUM
   Luminate Aesthetics Ltd shows improving financial health with positive net current assets and shareholders' funds in its latest financial year, indicating solvency. However, the company is very small, with limited turnover and a single employee, which may constrain operational stability and growth prospects.

2. Key Concerns:

• Size and Scale: The company is micro-sized with minimal fixed assets (£636) and limited receivables (£120), which may limit its ability to absorb financial shocks or scale operations.
• Debtor Reduction: Debtors dropped sharply from £2,600 in 2023 to £120 in 2024, which could reflect lower sales or changes in credit policy—this merits investigation as it impacts cash flow reliability.
• Concentration of Control: One director (and significant shareholder) holds 75-100% of voting rights and director appointment rights, which may raise governance concerns, especially in a small company with limited oversight.

3. Positive Indicators:

• Improved Liquidity: Cash reserves more than doubled to £8,615 in 2024, improving the company’s ability to meet short-term liabilities (£5,349).
• Solvency Improvement: Net current assets swung from negative (£725) in 2023 to positive (£3,386) in 2024, showing the company’s balance sheet strengthening.
• Compliance: The company is current with filing accounts and confirmation statements, with no overdue filings noted, indicating good regulatory compliance.

4. Due Diligence Notes:

• Verify the nature and sustainability of cash inflows given the sharp decline in debtors and the small scale of operations.
• Assess the company’s revenue trends and profitability details, which are not disclosed in the filleted accounts, to understand operational viability.
• Review governance arrangements given the concentration of control and single director, particularly regarding decision-making and risk management.